A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19.Moderna released the first human results from its coronavirus vaccine candidate on Monday.
The Massachusetts biotech described Monday the immune system responses to the vaccine from this first, small study that was primarily focused on safety. The results don't yet show whether the vaccine would prevent people from being infected with the novel coronavirus. All participants developed detectable antibodies, and Moderna said there were "dose dependent increases in immunogenicity" across the three potencies.
Portosj81 Hydroxychloroquine double blind trial test for covid19 will not be complete until next year. Yet their bragging about success of a vaccine in three months.
Portosj81 Should have everyone concerned about proper testing.
Boi_tu_me_lo
Business Insider already reported this, but here goes. Why is this not a little suspicious?
Well Trump's ready to distribute 300 million doses then. Why slow down 'Operation Warp Speed' with those pesky safety trials, that only the libs want. Below is how I feel about anti-vaxxers, but we've never had a madman in charge of vaccines before! TRANSITION TO BIDEN
I wonder if they'll make a public good if it proves effective at scale.
ahmad_shahzwan habisla degree first sem kena face to face... Aku nak online 😭
My body my choice I won't take no shot
It will be the first product they ever got to market. Nothing out of trials. Nothing FDA approved. Nothing sold yet. Just saying we are getting excited about a company that has never made a pharma product for public use.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: BusinessInsider - 🏆 729. / 51 Weiterlesen »